| UCB-Pharma SA - Vimpat 50 mg, comprimés pelliculés | | 59002 | | 01 | | Vimpat 50 mg | | comprimés pelliculés | | N03AX18 | | Lacosamide | | 28.08.2009 | | |
| | Composition | | lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 132, E 171, E 172 (rubrum), E 172 (nigrum) pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | | | | | | | | | Macrogol | 3350 | | | | | | | | | pellicule | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 14 Tablet(s) | 5.45 | 15.10 | B | SL | Yes |
|
|
